Results 281 to 290 of about 5,310,608 (313)
Some of the next articles are maybe not open access.

Oxysterols and neurodegenerative diseases

Molecular Aspects of Medicine, 2009
In contrast to their parent molecule cholesterol, two of its side-chain oxidized metabolites are able to cross the blood-brain barrier. There is a concentration-driven flux of 24S-hydroxycholesterol (24S-OHC) from the brain into the circulation, which is of major importance for elimination of excess cholesterol from the brain.
Björkhem I   +3 more
openaire   +2 more sources

MicroRNAs in Neurodegenerative Diseases

2017
MicroRNAs are small noncoding RNAs that regulate gene expression at the posttranscriptional level in a sequence-specific manner. After their discovery in 1993, mounting data have provided compelling evidence for their causal involvement in several human diseases, such as cancer and disorders of the brain.
Sean, Quinlan   +4 more
openaire   +2 more sources

Ceruloplasmin in neurodegenerative diseases

Biochemical Society Transactions, 2008
Two decades ago, patients lacking circulating serum ceruloplasmin (Cp) presented with neurodegeneration associated with brain iron accumulation. These patients, with mutations in the MCO (multi-copper oxidase), Cp, revealed an essential role for Cp in iron homoeostasis.
Sarah J, Texel   +2 more
openaire   +2 more sources

Sumoylation in neurodegenerative diseases

Cellular and Molecular Life Sciences, 2012
The yeast SUMO (small ubiquitin-like modifier) orthologue SMT3 was initially discovered in a genetic suppressors screen for the centromeric protein Mif2 (Meluh and Koshland in Mol Bio Cell 6:793-807, 1). Later, it turned out that the homologous mammalian proteins SUMO1 to SUMO4 are reversible protein modifiers that can form isopeptide bonds with lysine
Petranka, Krumova, Jochen H, Weishaupt
openaire   +2 more sources

Ageing and neurodegenerative diseases

Ageing Research Reviews, 2010
Ageing, which all creatures must encounter, is a challenge to every living organism. In the human body, it is estimated that cell division and metabolism occurs exuberantly until about 25 years of age. Beyond this age, subsidiary products of metabolism and cell damage accumulate, and the phenotypes of ageing appear, causing disease formation.
Chia-Wei, Hung   +4 more
openaire   +2 more sources

Cannabinoids and Neurodegenerative Diseases

CNS & Neurological Disorders - Drug Targets, 2009
Although significant advances have taken place in recent years on our understanding of the molecular mechanisms of different neurodegenerative diseases, its translation into effective therapeutic treatments has not been as successful as could be expected.
J, Romero, J Martínez, Orgado
openaire   +2 more sources

Glaucoma as a Neurodegenerative Disease

Journal of Neuro-Ophthalmology, 2015
The primary pathophysiological feature of glaucoma is a progressive optic neuropathy with characteristic morphological changes of the optic disc and risk factors of age and intraocular pressure. Recently, involvement of other areas of the central nervous system (CNS) beyond the optic nerve has been demonstrated.
Helen V, Danesh-Meyer, Leonard A, Levin
openaire   +2 more sources

Biomarkers in Neurodegenerative Diseases

2017
The past decade has seen tremendous efforts in biomarker discovery and validation for neurodegenerative diseases. The source and type of biomarkers has continued to grow for central nervous system diseases, from biofluid-based biomarkers (blood or cerebrospinal fluid (CSF)), to nucleic acids, tissue, and imaging.
Andreas, Jeromin, Robert, Bowser
openaire   +2 more sources

AMPK in Neurodegenerative Diseases

2016
Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis are neurodegenerative disorders that are characterized by a progressive degeneration of nerve cells eventually leading to dementia. While these diseases affect different neuronal populations and present distinct clinical features, they share in common ...
Manon, Domise, Valérie, Vingtdeux
openaire   +2 more sources

SYK coordinates neuroprotective microglial responses in neurodegenerative disease

Cell, 2022
Daniel Shapiro   +2 more
exaly  

Home - About - Disclaimer - Privacy